These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives? Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F. Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798 [Abstract] [Full Text] [Related]
4. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill? Mills A, Wilkinson C, Fotherby K. Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763 [Abstract] [Full Text] [Related]
6. Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene. Santamaría A, Mateo J, Oliver A, Menéndez B, Souto JC, Borrell M, Soria JM, Tirado I, Fontcuberta J. Haematologica; 2001 Sep; 86(9):965-71. PubMed ID: 11532625 [Abstract] [Full Text] [Related]
9. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?]. Plu-Bureau G, Horellou MH, Gompel A, Conard J. Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163 [Abstract] [Full Text] [Related]
13. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment. Santamaria MG, Agnelli G, Taliani MR, Prandoni P, Moia M, Bazzan M, Guazzaloca G, Ageno W, Bertoldi A, Silingardi M, Tomasi C, Ambrosio GB, Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Thromb Res; 2005 Apr; 116(4):301-6. PubMed ID: 16038714 [Abstract] [Full Text] [Related]
14. Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism. Andersen BS, Olsen J, Nielsen GL, Steffensen FH, Sørensen HT, Baech J, Gregersen H. Thromb Haemost; 1998 Jan; 79(1):28-31. PubMed ID: 9459317 [Abstract] [Full Text] [Related]
15. Efficacy of family history in determining thrombophilia risk. Dietrich JE, Hertweck SP, Perlman SE. J Pediatr Adolesc Gynecol; 2007 Aug; 20(4):221-4. PubMed ID: 17673133 [Abstract] [Full Text] [Related]
16. High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects. Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJ, van der Meer J. Br J Haematol; 2007 Jul; 138(1):110-6. PubMed ID: 17555454 [Abstract] [Full Text] [Related]
17. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group. Circulation; 2005 Nov 29; 112(22):3495-500. PubMed ID: 16301339 [Abstract] [Full Text] [Related]
18. [Pregnancy, contraception and HRT and venous thromboembolism]. Conard J, Gompel A. Rev Prat; 2007 Apr 15; 57(7):759-66. PubMed ID: 17626321 [Abstract] [Full Text] [Related]